Here are a couple of great ideas on where to invest your money today.
These stocks have rock-solid businesses and they have impressive track records for paying dividends.
These great stocks are great picks for investors as spring winds down.
Eli Lilly has made inroads in the red-hot weight-loss market thanks to its diabetes blockbuster, Mounjaro.
Where there's a will, there's a way. And Pfizer appears to have the will to stake a claim in the massive obesity drug market.
The anti-obesity medication stock is way up, and there could be more fuel in the tank.
The company delivered solid quarterly results, but its discussion of an investigational drug is what really gave its shares a pop.
The path is clear for even more growth from Novo Nordisk's top two drugs, Ozempic and Wegovy.
The company seems to be going from strength to strength lately.
Novo Nordisk (NVO), known for its popular weight-loss drug Wegovy, has seen its shares surge by more than 350% since 2020, yet it continues to trade at a 30% discount to its main U.S. competitor, Eli Lilly...